Notch Therapeutics

David Main, President and CEO

Oct. 8 | 12:00pm | FLW Ballroom G 

Vancouver, BC

(Private)

Notch is working to broaden the applicability and increase accessibility of cell therapy. Built on foundational discoveries in developmental immunology and enabled by world-class bioengineering and advanced cell manufacturing teams, we have demonstrated unprecedented production of functional T cells from iPSCs using proprietary, scalable, small-footprint manufacturing systems. Notch has the potential to fully enable best-in-class commercial manufacturing and product designs for accessible and effective off-the-shelf immmunotherapies.

www.notchtx.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions